Bringing a new therapeutic product from a process development laboratory into GMP manufacturing is a major milestone. While research processes are designed to demonstrate proof of concept, GMP manufacturing requires a process that is robust, reproducible and capable of consistently producing product that meets quality standards.
Moving into GMP before you are ready can result in delays, deviations and unnecessary costs. Before taking this step, sponsors should consider whether their process is truly ready.
Is Your Process Well Understood?
Successful laboratory experiments are only the beginning. Before GMP manufacture, you should understand the critical process parameters, expected product quality and sources of variability. A process that consistently delivers the same outcome is far more likely to transfer successfully into a GMP facility.
Are Your Materials and Formulation Ready?
Research-grade materials may not be suitable for clinical manufacturing. Key raw materials should be appropriately qualified and available from reliable suppliers. In addition, the formulation should be appropriately developed to avoid significant changes once GMP manufacturing has commenced.
Can the Process Be Manufactured Aseptically?
Sterile manufacturing requires careful consideration of contamination risks. Processes should minimise open handling, unnecessary interventions and other activities that could compromise sterility. Designing with aseptic manufacture in mind from an early stage can simplify the transition into GMP production.
Is the Required Documentation in Place?
Clear documentation is fundamental to GMP compliance. Manufacturing work instructions, material specifications, risk assessments and Standard Operating Procedures (SOPs) should all be development and implemented well before manufacturing begins. Effective documentation helps ensure consistency and reduces the risk of errors during manufacturing.
Have You Planned for Technology Transfer?
Technology transfer involves much more than sharing a manufacturing protocol. It requires effective communication between the development team and the manufacturing site, allowing practical challenges to be identified and addressed before GMP production starts. Engineering batches and collaborative planning can significantly improve the likelihood of a successful transfer.
The transition from laboratory development to sterile GMP manufacturing is a critical step that requires confidence that your process can consistently deliver high-quality product within a controlled manufacturing environment. Taking the time to evaluate process readiness can reduce risks, avoid costly delays and provide a stronger foundation for clinical supply. Engaging with an experienced manufacturing partner early can also help identify potential gaps before they become potential issues during GMP production.
We offer sterile manufacturing and aseptic fill-finish services within our GMP-certified cleanrooms. Our experienced team is committed to delivering the highest standards of compliance, quality, and reliability. If you’re seeking a trusted CDMO partner capable of providing exceptional results and ensuring continuity of supply, we’d be delighted to speak with you. Contact our team today and schedule a call to learn more.